CytomX Therapeutics CTMX Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's total revenue?
- CytomX Therapeutics (CTMX) reported total revenue of $10.26M in Q1 2026.
- How has CytomX Therapeutics's total revenue changed year-over-year?
- CytomX Therapeutics's total revenue decreased by 79.9% year-over-year, from $50.92M to $10.26M.
- What is the long-term trend for CytomX Therapeutics's total revenue?
- Over 4 years (2021 to 2025), CytomX Therapeutics's total revenue has grown at a 19.5% compound annual growth rate (CAGR), from $37.31M to $76.2M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.